BRSF — Brain Scientific Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -243.27% | ||
| Return on Equity | -681.55% | ||
| Operating Margin | -4903.8% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.06 | 0.49 | 0.54 | 0.27 | 0.21 | n/a | n/a | 98.17% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Brain Scientific Inc. is a medical technology (MedTech) company with two product lines, such as neurology and motion products. The Company has two subsidiaries, each of which is focused on one of its complementary product lines. The neurology products of its subsidiary, Memory MD, Inc., are medical devices and software products designed for the neurology market. The products of its subsidiary, Piezo Motion Corp. are motion products, which are small piezoelectric motors designed for use as motors within medical devices and devices outside of the MedTech industry. It has developed about twelve motor platforms and micro dosing pumps, each of which is available commercially. Its NeuroCap is a disposable, soft layered cap with an integrated electrode circuit that is designed to address problems of conventional electroencephalography (EEG) systems. The NeuroEEG connects wirelessly to the computer, allowing freedom of movement for the patient and enabling telemedicine applications.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- November 18th, 2013
- Public Since
- August 16th, 2017
- No. of Shareholders
- 139
- No. of Employees
- 11
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 1,242,647
- Address
- 6700 PROFESSIONAL PARKWAY, SARASOTA, 34240
- Web
- https://www.brainscientific.com/
- Phone
- +1 9173881578
- Auditors
- Accell Audit & Compliance, P.A
Upcoming Events for BRSF
Similar to BRSF
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 19:40 UTC, shares in Brain Scientific are trading at $0.75. This share price information is delayed by 15 minutes.
Shares in Brain Scientific last closed at $0.75 and the price had moved by -92.4% over the past 365 days. In terms of relative price strength the Brain Scientific share price has underperformed the S&P500 Index by -92.9% over the past year.
There is no consensus recommendation for this security.
Find out moreBrain Scientific does not currently pay a dividend.
Brain Scientific does not currently pay a dividend.
Brain Scientific does not currently pay a dividend.
To buy shares in Brain Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.75, shares in Brain Scientific had a market capitalisation of .
Here are the trading details for Brain Scientific:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: BRSF
Based on an overall assessment of its quality, value and momentum Brain Scientific is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Brain Scientific. Over the past six months, its share price has underperformed the S&P500 Index by -85.88%.
As of the last closing price of $0.75, shares in Brain Scientific were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Brain Scientific PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Brain Scientific's directors